OMDA

Omada Health, Inc.

Morgan Stanley, Evercore ISI, and Barclays raised price targets to between $28–$32, citing Omada’s revenue growth and its first positive adjusted EBITDA.

Teacher Retirement System of Texas bought a new position in Omada Health, Inc. (NASDAQ:OMDA - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities...

Barclays increased their target price on shares of Omada Health from $28.00 to $29.00 and gave the stock an "overweight" rating in a research report on Friday...

Omada Health (NASDAQ:OMDA) Trading Down 11.1% - Here's Why...

Evercore ISI increased their target price on Omada Health from $27.00 to $28.00 and gave the stock an "outperform" rating in a research report on Friday...

Needham & Company LLC increased their price objective on shares of Omada Health from $26.00 to $28.00 and gave the stock a "buy" rating in a research note on Friday...

Omada Health (NASDAQ:OMDA - Get Free Report) announced its quarterly earnings results on Thursday. The company reported ($0.03) EPS for the quarter, beating the consensus estimate of ($0.24) by $0.21...

The headline numbers for Omada Health, Inc. (OMDA) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

The announcement expands the offerings under the company's weight management program as its membership grows to more than 100,000...